223 related articles for article (PubMed ID: 11826911)
1. A double-blind, placebo-controlled, and randomized study of loratadine (Clarityne) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years.
Yang YH; Lin YT; Lu MY; Tsai MJ; Chiang BL
Asian Pac J Allergy Immunol; 2001 Sep; 19(3):171-5. PubMed ID: 11826911
[TBL] [Abstract][Full Text] [Related]
2. Brompheniramine, loratadine, and placebo in allergic rhinitis: a placebo-controlled comparative clinical trial.
Druce HM; Thoden WR; Mure P; Furey SA; Lockhart EA; Xie T; Galant S; Prenner BM; Weinstein S; Ziering R; Brandon ML
J Clin Pharmacol; 1998 Apr; 38(4):382-9. PubMed ID: 9590467
[TBL] [Abstract][Full Text] [Related]
3. Double-blind comparison of cetirizine and loratadine in children ages 2 to 6 years with perennial allergic rhinitis.
Sienra-Monge JJ; Gazca-Aguilar A; Del Rio-Navarro B
Am J Ther; 1999 May; 6(3):149-55. PubMed ID: 10423657
[TBL] [Abstract][Full Text] [Related]
4. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
[TBL] [Abstract][Full Text] [Related]
5. A parallel-group comparison of astemizole and loratadine for the treatment of perennial allergic rhinitis.
al-Muhaimeed H
J Int Med Res; 1997; 25(4):175-81. PubMed ID: 9283989
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis.
Simons FE; Prenner BM; Finn A;
J Allergy Clin Immunol; 2003 Mar; 111(3):617-22. PubMed ID: 12642846
[TBL] [Abstract][Full Text] [Related]
7. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
Ratner PH; Lim JC; Georges GC
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
Van Cauwenberge P; Juniper EF
Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine.
Berger WE; White MV;
Ann Allergy Asthma Immunol; 2003 Aug; 91(2):205-11. PubMed ID: 12952117
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
Hampel F; Howland W; Van Bavel J; Ratner P
J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
Herman D; Garay R; Le Gal M
Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
Saint-Martin F; Dumur JP; Pérez I; Izquierdo I;
J Investig Allergol Clin Immunol; 2004; 14(1):34-40. PubMed ID: 15160440
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pseudoephedrine in perennial allergic rhinitis].
Hernández Colín D; González Díaz SN; Rodríguez Medina R; Aguilar Angeles D; González Gámez J; Becerril Angeles M; Orea Solano M; Domínguez Henkel R; Segovia Ayala C
Rev Alerg Mex; 2004; 51(1):23-8. PubMed ID: 15119752
[TBL] [Abstract][Full Text] [Related]
14. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
Nunes C; Ladeira S
J Investig Allergol Clin Immunol; 2000; 10(1):20-3. PubMed ID: 10780795
[TBL] [Abstract][Full Text] [Related]
15. Prevention of recurrent wheezing in young children by loratadine compared with ketotifen.
Ngamphaiboon J; Wirawarn T; Thongkaew T
J Med Assoc Thai; 2009 Mar; 92(3):351-5. PubMed ID: 19301727
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of loratadine syrup and cyproheptadine HCL solution for treating perennial allergic rhinitis in Taiwanese children aged 2-12 years.
Wu KG; Li TH; Wang TY; Hsu CL; Chen CJ
Int J Immunopathol Pharmacol; 2012; 25(1):231-7. PubMed ID: 22507335
[TBL] [Abstract][Full Text] [Related]
18. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis.
Chiang YC; Shyur SD; Chen TL; Huang LH; Wen TC; Lin MT; Yang HC; Liang PH; Kao YH; Wang TC
Asian Pac J Allergy Immunol; 2006; 24(2-3):97-103. PubMed ID: 17136873
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Ratner P; Hampel F; Van Bavel J; Howland W
Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
